120 related articles for article (PubMed ID: 38608254)
41. Molecular and clinical progress in follicular lymphoma lacking the t(14;18) translocation (Review).
Zhu Z; Li T; Zhang X; Zhang Z; Zhu D; Lin P; Tu S; Ren W
Int J Oncol; 2020 Jan; 56(1):7-17. PubMed ID: 31789408
[TBL] [Abstract][Full Text] [Related]
42. The t(14;18)(q32;q21)/IGH-MALT1 translocation in gastrointestinal extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma).
Zhang S; Wei M; Liang Q; Johnson D; Dow N; Nelson A; Aguilera N; Auerbach A; Wang G
Histopathology; 2014 May; 64(6):791-8. PubMed ID: 24236896
[TBL] [Abstract][Full Text] [Related]
43. Distribution of BCL2 breakpoints in follicular lymphoma and correlation with clinical features: specific subtypes or same disease?
Buchonnet G; Jardin F; Jean N; Bertrand P; Parmentier F; Tison S; Lepretre S; Contentin N; Lenain P; Stamatoullas-Bastard A; Tilly H; Bastard C
Leukemia; 2002 Sep; 16(9):1852-6. PubMed ID: 12200703
[TBL] [Abstract][Full Text] [Related]
44. FISH analysis of MALT lymphoma-specific translocations and aneuploidy in primary cutaneous marginal zone lymphoma.
Schreuder MI; Hoefnagel JJ; Jansen PM; van Krieken JH; Willemze R; Hebeda KM
J Pathol; 2005 Feb; 205(3):302-10. PubMed ID: 15682432
[TBL] [Abstract][Full Text] [Related]
45. Chromosomal Aberration t(14;17)(q32;q21) Simultaneously Activates HOXB5 and miR10a in Triple-Hit B-Cell Lymphoma.
Nagel S; Pommerenke C; Meyer C; Kaufmann M; MacLeod RAF
Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371852
[No Abstract] [Full Text] [Related]
46. Concurrent activation of MYC and BCL2 in B cell non-Hodgkin lymphoma cell lines by translocation of both oncogenes to the same immunoglobulin heavy chain locus.
Dyer MJ; Lillington DM; Bastard C; Tilly H; Lens D; Heward JM; Stranks G; Morilla R; Monrad S; Guglielmi P; Kluin-Nelemans JC; Hagemeijer A; Young BD; Catovsky D
Leukemia; 1996 Jul; 10(7):1198-208. PubMed ID: 8684002
[TBL] [Abstract][Full Text] [Related]
47. Oral follicular lymphomas. A short report of 8 cases with assessment of the IGH/BCL2 gene fusion with fluorescence in situ hybridization.
Argyris PP; Dolan M; Piperi E; Tosios KI; Pambuccian SE; Koutlas IG
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Sep; 116(3):343-7. PubMed ID: 23953419
[TBL] [Abstract][Full Text] [Related]
48. Primary follicular lymphoma of the epididymis positive for t(14;18)(q32;q21)/IGH-BCL2 and negative for BCL2 protein expression: a case report.
Tralongo V; Becchina G; Nagar C; Ottoveggio G; Mason S; Seno B; Sessa F; Frattini M; Genovese F
J Med Case Rep; 2012 Jan; 6():24. PubMed ID: 22257663
[TBL] [Abstract][Full Text] [Related]
49. BCL2 gene abnormalities define distinct clinical subsets of follicular lymphoma.
Goodlad JR; Batstone PJ; Hamilton DA; Kernohan NM; Levison DA; White JM
Histopathology; 2006 Sep; 49(3):229-41. PubMed ID: 16918969
[TBL] [Abstract][Full Text] [Related]
50. Clinical utility of next generation sequencing to detect IGH/IL3 rearrangements [t(5;14)(q31.1;q32.1)] in B-lymphoblastic leukemia/lymphoma.
Guenzel AJ; Smadbeck JB; Golden CL; Williamson CM; Benevides Demasi JC; Vasmatzis G; Pearce KE; Olteanu H; Xu X; Hoppman NL; Greipp PT; Baughn LB; Ketterling RP; Peterson JF
Ann Diagn Pathol; 2021 Aug; 53():151761. PubMed ID: 33991782
[TBL] [Abstract][Full Text] [Related]
51. Identification of novel, clonally stable, somatic mutations targeting transcription factors PAX5 and NKX2-3, the epigenetic regulator LRIF1, and BRAF in a case of atypical B-cell chronic lymphocytic leukemia harboring a t(14;18)(q32;q21).
Burlet B; Ramla S; Fournier C; Abrey-Recalde MJ; Sauter C; Chrétien ML; Rossi C; Duffourd Y; Ragot S; Buriller C; Tournier B; Chapusot C; Nadal N; Racine J; Guy J; Bailly F; Martin L; Casasnovas O; Bastie JN; Caillot D; Albuisson J; Broccardo C; Thieblemont C; Delva L; Maynadié M; Aucagne R; Callanan MB
Cold Spring Harb Mol Case Stud; 2021 Feb; 7(1):. PubMed ID: 33608382
[TBL] [Abstract][Full Text] [Related]
52. Cryptic IGH/BCL2 rearrangements with variant FISH patterns in follicular lymphoma.
Baró C; Espinet B; Salido M; García M; Sánchez B; Florensa L; Bellosillo B; Serrano S; Solé F
Leuk Res; 2011 Feb; 35(2):256-9. PubMed ID: 20952062
[TBL] [Abstract][Full Text] [Related]
53. Characterization of a case of follicular lymphoma transformed into B-lymphoblastic leukemia.
Ning Y; Foss A; Kimball AS; Neill N; Matz T; Schultz R
Mol Cytogenet; 2013 Aug; 6(1):34. PubMed ID: 23985173
[TBL] [Abstract][Full Text] [Related]
54. Genetic and immunophenotypic profile of IGH@ rearrangement detected by fluorescence in situ hybridization in 149 cases of B-cell chronic lymphocytic leukemia.
Lu G; Kong Y; Yue C
Cancer Genet Cytogenet; 2010 Jan; 196(1):56-63. PubMed ID: 19963136
[TBL] [Abstract][Full Text] [Related]
55. t(9;14)(p13;q32)/PAX5-IGH translocation as a secondary cytogenetic abnormality in diffuse large B-cell lymphoma.
Ohno H; Takeoka K; Kishimori C; Nakagawa M; Fukutsuka K; Maekawa F; Hayashida M; Akasaka T; Sumiyoshi S
J Clin Exp Hematop; 2021 Dec; 61(4):216-220. PubMed ID: 34707037
[TBL] [Abstract][Full Text] [Related]
56. Follicular lymphoma with t(8;14)(q24;q32): a distinct clinical and molecular subset of t(8;14)-bearing lymphomas.
Ladanyi M; Offit K; Parsa NZ; Condon MR; Chekka N; Murphy JP; Filippa DA; Jhanwar SC; Dalla-Favera R; Chaganti RS
Blood; 1992 Apr; 79(8):2124-30. PubMed ID: 1562738
[TBL] [Abstract][Full Text] [Related]
57. MALT lymphoma with t(14;18)(q32;q21)/IGH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression.
Ye H; Gong L; Liu H; Hamoudi RA; Shirali S; Ho L; Chott A; Streubel B; Siebert R; Gesk S; Martin-Subero JI; Radford JA; Banerjee S; Nicholson AG; Ranaldi R; Remstein ED; Gao Z; Zheng J; Isaacson PG; Dogan A; Du MQ
J Pathol; 2005 Feb; 205(3):293-301. PubMed ID: 15682443
[TBL] [Abstract][Full Text] [Related]
58. Detection of rearrangements of the BCL2 major breakpoint region in follicular lymphomas. Correlation of polymerase chain reaction results with Southern blot analysis.
Ladanyi M; Wang S
Diagn Mol Pathol; 1992 Mar; 1(1):31-5. PubMed ID: 1342952
[TBL] [Abstract][Full Text] [Related]
59. Identification of two distinct MYC breakpoint clusters and their association with various IGH breakpoint regions in the t(8;14) translocations in sporadic Burkitt-lymphoma.
Busch K; Keller T; Fuchs U; Yeh RF; Harbott J; Klose I; Wiemels J; Novosel A; Reiter A; Borkhardt A
Leukemia; 2007 Aug; 21(8):1739-51. PubMed ID: 17541401
[TBL] [Abstract][Full Text] [Related]
60. A marginal zone phenotype in follicular lymphoma with t(14;18) is associated with secondary cytogenetic aberrations typical of marginal zone lymphoma.
Torlakovic EE; Aamot HV; Heim S
J Pathol; 2006 Jun; 209(2):258-64. PubMed ID: 16583359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
